UA123330C2 - Гетероароматичні модулятори ретинол-зв'язаного орфанного рецептора гамма - Google Patents

Гетероароматичні модулятори ретинол-зв'язаного орфанного рецептора гамма Download PDF

Info

Publication number
UA123330C2
UA123330C2 UAA201901406A UAA201901406A UA123330C2 UA 123330 C2 UA123330 C2 UA 123330C2 UA A201901406 A UAA201901406 A UA A201901406A UA A201901406 A UAA201901406 A UA A201901406A UA 123330 C2 UA123330 C2 UA 123330C2
Authority
UA
Ukraine
Prior art keywords
methyl
oxadiazol
carboxylate
methylpiperazine
alkyl
Prior art date
Application number
UAA201901406A
Other languages
English (en)
Ukrainian (uk)
Inventor
Алан Стюарт Йєссіман
Алан Стюарт Йессиман
Патрік Стефен Джонсон
Патрик Стефен Джонсон
Крістоффер Монссон
Кристоффер МОНССОН
Мортен Дахль Соренсен
Original Assignee
Лео Фарма А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лео Фарма А/С filed Critical Лео Фарма А/С
Publication of UA123330C2 publication Critical patent/UA123330C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
UAA201901406A 2016-07-13 2017-07-11 Гетероароматичні модулятори ретинол-зв'язаного орфанного рецептора гамма UA123330C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16020268 2016-07-13
PCT/EP2017/067390 WO2018011201A1 (en) 2016-07-13 2017-07-11 Heteroaromatic modulators of the retinoid-related orphan receptor gamma

Publications (1)

Publication Number Publication Date
UA123330C2 true UA123330C2 (uk) 2021-03-17

Family

ID=56511303

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201901406A UA123330C2 (uk) 2016-07-13 2017-07-11 Гетероароматичні модулятори ретинол-зв'язаного орфанного рецептора гамма

Country Status (21)

Country Link
US (2) US10662181B2 (cg-RX-API-DMAC7.html)
EP (1) EP3484880B1 (cg-RX-API-DMAC7.html)
JP (1) JP7016344B2 (cg-RX-API-DMAC7.html)
KR (1) KR102490140B1 (cg-RX-API-DMAC7.html)
CN (1) CN109476653B (cg-RX-API-DMAC7.html)
AU (1) AU2017294969B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019000486A2 (cg-RX-API-DMAC7.html)
CA (1) CA3030370A1 (cg-RX-API-DMAC7.html)
DK (1) DK3484880T3 (cg-RX-API-DMAC7.html)
ES (1) ES2834009T3 (cg-RX-API-DMAC7.html)
IL (1) IL264141B (cg-RX-API-DMAC7.html)
MX (1) MX383770B (cg-RX-API-DMAC7.html)
MY (1) MY196990A (cg-RX-API-DMAC7.html)
PL (1) PL3484880T3 (cg-RX-API-DMAC7.html)
PT (1) PT3484880T (cg-RX-API-DMAC7.html)
RU (1) RU2771280C2 (cg-RX-API-DMAC7.html)
SA (1) SA519400868B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201811107WA (cg-RX-API-DMAC7.html)
UA (1) UA123330C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018011201A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201808436B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2771280C2 (ru) * 2016-07-13 2022-04-29 Лео Фарма А/С Гетероароматические модуляторы ретинол-связанного орфанного рецептора гамма
CN111825654A (zh) * 2019-04-19 2020-10-27 北京酷瓴生物技术有限公司 苯甲烯哌啶衍生物及其制备方法、中间体和用途
CN112898292A (zh) * 2019-12-03 2021-06-04 微境生物医药科技(上海)有限公司 新型极光激酶抑制剂及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS244821B2 (en) * 1983-06-16 1986-08-14 Boehringer Ingelheim Ltd Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
WO2004073612A2 (en) 2003-02-13 2004-09-02 Merck & Co. Inc. Estrogen receptor modulators
FR2879381B1 (fr) 2004-12-15 2008-12-26 Thales Sa Systeme de distribution quantique de cle de cryptage a variables continues
MX2007012392A (es) * 2005-04-04 2007-12-05 Ab Science Derivados de oxazol sustituidos y su uso como inhibidores de tirosina cinasa.
EP2511275A1 (en) 2011-04-12 2012-10-17 Bioprojet Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists
SI2928885T1 (sl) * 2012-12-06 2017-06-30 Glaxo Group Limited Modulatorji retinoidnemu sorodnega receptorja gama sirote (ror-gama) za uporabo pri zdravljenju avtoimunskih in vnetnih bolezni
WO2015067575A1 (en) * 2013-11-05 2015-05-14 F. Hoffmann-La Roche Ag 5,6,7,8-tetrahydro-5,8-methanocinnoline derivatives as rorc modulators for the treatment of autoimmune diseases
WO2015180613A1 (en) * 2014-05-28 2015-12-03 Glaxosmithkline Intellectual Property Development Limited Novel compounds
WO2015180612A1 (en) 2014-05-28 2015-12-03 Glaxosmithkline Intellectual Property Development Limited Novel compounds
ES2716966T3 (es) * 2014-05-28 2019-06-18 Glaxosmithkline Ip Dev Ltd Derivados de piperazina como moduladores de ROR-gamma
RU2771280C2 (ru) * 2016-07-13 2022-04-29 Лео Фарма А/С Гетероароматические модуляторы ретинол-связанного орфанного рецептора гамма

Also Published As

Publication number Publication date
RU2771280C2 (ru) 2022-04-29
US20190284177A1 (en) 2019-09-19
CA3030370A1 (en) 2018-01-18
US20200291010A1 (en) 2020-09-17
US10934282B2 (en) 2021-03-02
AU2017294969B2 (en) 2021-03-25
ZA201808436B (en) 2020-05-27
ES2834009T3 (es) 2021-06-16
SA519400868B1 (ar) 2022-06-13
MX383770B (es) 2025-03-14
PL3484880T3 (pl) 2021-04-06
IL264141B (en) 2021-09-30
PT3484880T (pt) 2020-12-07
RU2019103883A (ru) 2020-08-13
NZ749301A (en) 2021-03-26
US10662181B2 (en) 2020-05-26
EP3484880B1 (en) 2020-09-02
JP2019521137A (ja) 2019-07-25
JP7016344B2 (ja) 2022-02-04
IL264141A (en) 2019-02-28
MY196990A (en) 2023-05-17
SG11201811107WA (en) 2019-01-30
CN109476653A (zh) 2019-03-15
WO2018011201A1 (en) 2018-01-18
KR20190026872A (ko) 2019-03-13
CN109476653B (zh) 2022-04-22
RU2019103883A3 (cg-RX-API-DMAC7.html) 2020-09-23
BR112019000486A2 (pt) 2019-04-24
MX2019000361A (es) 2019-05-23
EP3484880A1 (en) 2019-05-22
AU2017294969A1 (en) 2019-01-17
KR102490140B1 (ko) 2023-01-19
DK3484880T3 (da) 2020-11-09

Similar Documents

Publication Publication Date Title
US10961225B2 (en) Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor
AU722883B2 (en) Cyclopentyl tachykinin receptor antagonists
CA2959615C (en) Tetrahydronaphthalene derivatives that inhibit mcl-1 protein
AU2014212465B2 (en) S1P modulating agents
HU230612B1 (hu) Kemokin receptorokat módosító hatású 3-aminopirrolidin-származékok
CA2994143A1 (en) Muscarinic agonists
UA118369C2 (uk) Сполуки, що інгібують активність lrrk2 кінази
EP3532462B1 (en) Acyl sulfonamide nav1.7 inhibitors
UA121133C2 (uk) Біциклічні похідні хіназолінону
CA3072926A1 (en) Spirocycle compounds and methods of making and using same
US10934282B2 (en) Heteroaromatic modulators of the retinoid-related orphan receptor gamma
CA2935012A1 (en) Aryl sultam derivatives as rorc modulators
WO2007003965A1 (en) Substituted cyclohexyl derivatives as nk-3 receptor antagonists
ES2547415T3 (es) Derivados de oxiindol con actividad agonista del receptor de motilina
EP4466266B1 (en) Fused heterocycles as 5-ht2a receptor agonists
EP3659602A1 (en) Therapeutic agent or prophylactic agent for alopecia areata
US20240217978A1 (en) COMPOUND AS ADENOSINE A2a RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
KR20160106165A (ko) RORc 조절제로서의 헤테로아릴 설탐 유도체
NZ749301B2 (en) Heteroaromatic modulators of the retinoid-related orphan receptor gamma
EA049565B1 (ru) Замещенные макроциклические соединения, обладающие активностью агониста рецептора орексина-2, и их применение
HK40005345A (en) Heteroaromatic modulators of the retinoid-related orphan receptor gamma
WO2012115097A1 (ja) グリシントランスポーター阻害物質
NZ614321B2 (en) Glycine transporter-inhibiting substances